Not checked for notices yet.

Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis

Penny Whiting, Maiwenn Al, Laura Burgers and 7 more

Health Technology Assessment · 2014

doi:10.3310/hta18180

Cited by papers we hold 2

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine · 2020
No notice
Cystic fibrosis: current therapeutic targets and future approaches · 2017
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.